Consultant Oncologist · Kolkata

Dr. Suman
Meyur

MD (Radiation Oncology)  ·  MBBS  ·  ESMO  ·  ASCO  ·  FRSPH

A dynamic oncologist with expertise spanning radiation oncology, medical oncology, clinical research, and palliative care — committed to evidence-based, patient-centred cancer treatment across Kolkata.

15+ Years Experience
14+ Publications
4 Hospital Affiliations

Consultation Schedule

OPD Timings & Locations

Saroj Gupta Cancer Centre & Research Institute Thakurpukur, Kolkata
Wed & Fri 1:00 PM
Manipal Hospitals (prev. AMRI) Dhakuria, Kolkata
Thursday 4:00 PM · Prior Appt.
Ruby Cancer Centre Kolkata
Tuesday 5:30 PM · Prior Appt.
Narayan Memorial Hospital Kolkata
Sunday 10:00 AM
Prior appointment required at Manipal Hospitals & Ruby Cancer Centre. To book, call +91 96744 57101 or use the contact form below.

About

Oncology with
Precision & Compassion

Dr. Suman Meyur is a consultant oncologist with an MD in Radiation Oncology (First Class) from IPGMER & SSKM Hospital, West Bengal University of Health Sciences, and an MBBS (First Class) from Calcutta National Medical College. He is currently Deputy-in-Charge of Medical Oncology at Saroj Gupta Cancer Centre & Research Institute (SGCCRI), Thakurpukur, and a Specialist Consultant in the Department of Oncology at B.R. Singh Hospital (GOI), Kolkata.

A Visiting Faculty for Biostatistics and Advanced Epidemiology at NSHM Knowledge Campus under MAKAUT, Dr. Meyur blends academic rigour with frontline clinical practice across multiple centres in the city.

Certified by Harvard Medical School (2024), Stanford University (2016 & 2025), and the NIH/NIDA (2024), he carries internationally recognised credentials in oncology, clinical research, and evidence-based medicine.

Qualifications
MBBS (First Class)  ·  MD Radiation Oncology (First Class), IPGMER & SSKM Hospital, WBUHS
Current Positions
Deputy-in-Charge, Medical Oncology — SGCCRI, Thakurpukur  ·  Specialist Consultant (CMP) — Dept. of Oncology, B.R. Singh Hospital (GOI)  ·  Visiting Consultant — Ruby General Hospital & Cancer Center  ·  Consultant Clinical Oncology — Narayan Memorial Hospital
Fellowship & Academic
Fellowship in Intensive Care Medicine — Medvarsity, Apollo Hospitals, Hyderabad (2020–21)  ·  Visiting Faculty, Biostatistics & Advanced Epidemiology — NSHM Knowledge Campus, MAKAUT
Contact
sumanmeyur@yahoo.co.in  ·  +91 96744 57101

Specializations

Areas of
Clinical Expertise

01
Head & Neck Oncology

Hypofractionated palliative radiotherapy, concurrent chemoradiation, and management of oral, pharyngeal, laryngeal, and nasopharyngeal malignancies — backed by original peer-reviewed research.

02
Breast Oncology

Post-mastectomy hypofractionated radiation, HER2-targeted therapy, and comprehensive care from early-stage to metastatic breast cancer. Led prospective randomised dosimetric trials.

03
Gastrointestinal Cancers

Single-centre prospective study experience in GI stromal tumours; systemic and radiation management of colorectal, pancreatic, and hepatobiliary cancers.

04
Prostate & Urological Cancers

Real-world evidence-based management of metastatic hormone-sensitive prostate cancer including triplet therapy — co-authored in a landmark multicentre Indian study (2024).

05
Palliative & Supportive Care

Certified under the National Programme for Palliative Care (Govt. of West Bengal). Research focus on quality-adjusted survival and palliative intent radiotherapy for Stage IV disease.

06
Clinical Research & Trials

Co-PI in a Phase II Tipiracil/Trifluridine trial; peer reviewer for Elsevier and CG Publishing. Proficient in IBM SPSS, STATA, RevMan, and Elekta ONCENTRA TPS.

Research

Publications &
Certifications

Dr. Meyur has authored and co-authored over 14 peer-reviewed publications spanning radiation oncology, palliative care, GI oncology, breast cancer, and epidemiology. He is an active peer reviewer for Elsevier and CG Publishing (University of Illinois).

Key Certifications

2025Stanford University School of Medicine — Antibiotic Stewardship
2025Professional Diploma in Clinical Research
2024Harvard Medical School, Executive Education — Advanced Management of Oncological Diseases
2024NIDA, NIH Maryland USA — Good Clinical Practice Certification
2020Palliative Care Service — National Programme for Palliative Care, Govt. of West Bengal
2019Image Guided Radiotherapy: Clinical Implementation & Verification — AMPI, Eastern Chapter
20185th AROI-ICRO INTAS Radiobiology Teaching Course — Indian College of Radiation Oncology
2017National PG Teaching Course on Hypofractionation — 27th ICRO Program (PME/CME/2017/5117)
2016Stanford University (Lagunita) — Statistics in Medicine

Triplet therapy in metastatic hormone-sensitive prostate cancer: A real-world Indian multicentre study.

Mondal D, Roy S, Bhattacharjee A, Roy R, Meyur S, Biswas B. 2024

Epidemiology, prognostication and treatment outcome of gastrointestinal stromal tumour: A single centre prospective study.

Biomedicine. Prasad N, Meyur S, Das SM, Paul S, Basu S, Das S. 2023

A pilot study on feasibility, toxicity and efficacy of novel hypofractionated radiation therapy in advanced non-nasopharyngeal head and neck carcinoma treated with palliative intent.

Palliative Medicine in Practice. Meyur S, Pal SK, Maiti S, Basu S. 2021

Dynamics of Decision-Making in Medical Pluralism: A Systematic Review of Conceptual Models.

Alternative Therapies in Health & Medicine. Chowdhuri PD, Kundu K, Meyur S. 2022

The incidence of hypothyroidism in patients of head and neck carcinoma treated with radiotherapy and added risk of hypothyroidism with the addition of chemotherapy.

Journal of Radiotherapy in Practice. Singh D, Roy N, Pal SK, Basu S, Meyur S. 2022

Comparison of conventional and hypofractionated radiation after mastectomy in locally advanced breast cancer: a prospective randomised study on dosimetric evaluation and treatment outcome.

Journal of Radiotherapy in Practice. Maiti S, Meyur S, Mandal BC, Shenoi LR, Biswas S, Basu S. 2021

Analysis of Volumetric Dosimetry of Target Volumes and Organs at Risk on ICRU Point Based Dose Planning in CT-Guided HDR Intracavitary Brachytherapy to Carcinoma Cervix.

Indian Journal of Gynecologic Oncology. Maiti S, Pal SK, Meyur S, Mandal BC, Roy SB, Basu S. 2019

A Study on Optimization of Dose Distribution by Altering Dose Prescription Points in Post-Mastectomy Hypofractionated Chest Wall Irradiation.

Biomedicine. Maiti S, Meyur S, Pal S, Sardar P, Mandal BC, Basu S. 2018

Does Treatment Choice Vary with Disease? An Analysis of Demographic Factors and Disease Burden.

IMPACT: International Journal of Research in Applied, Natural and Social Sciences. Chowdhuri PD, Meyur S. 2018

Exploration of Personality Factors and their Effects on People's Decision Making of Complementary and Alternative Medicine.

International Journal of Management Studies (Vol. 5, No. 2). Chowdhuri PD, Meyur S. 2018

Primary extra nodal lymphoma: A rare case of gnathic involvement.

International Journal of Current Research. Roy S, Chatterjee R, Kundu S, Meyur S, Gayen S. 2018

Role of primary care providers in dengue prevention and control in the community: practitioners' and local laypersons' perspectives in Dhaka, Bangladesh.

International Journal of Integrated Care. Chowdhury PD, Haque CE, Meyur S. 2013

Comparison between Two Regimens of Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. [Poster]

Bengal Cancer Summit. Prasad N, Meyur S, Mirza B, Maiti S, Basu S. 2019

Memberships

Professional
Affiliations

FRSPH
Fellow of the Royal Society for Public Health, UK
MN – 132201
AROI
Association of Radiation Oncologists of India
LM – 3001
ESMO
European Society of Medical Oncology
ID – 422743
ASCO
American Society of Clinical Oncology
ID – 710938

Contact

Get in
Touch

For consultations, second opinions, or general enquiries, reach out via phone, email, or the form. All messages are responded to within 24 hours.

Email
sumanmeyur@yahoo.co.in
📞
Phone
+91 96744 57101
📍
Primary Base
SGCCRI, Thakurpukur, Kolkata, West Bengal
🗓
OPD Days
Tuesday · Wednesday · Thursday · Friday · Sunday

Send a Message

Dr. Meyur's team will get back to you shortly.

✓ Your message has been sent. Thank you.